Drug General Information
Drug ID
D0S6QR
Former ID
DNC000330
Drug Name
BMS-204352
Drug Type
Small molecular drug
Indication Nerve injury [ICD10:T14.4] Discontinued in Phase 3 [539459], [546835]
Structure
Download
2D MOL

3D MOL

Formula
C16H10ClF4NO2
InChI
InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1
InChIKey
ULYONBAOIMCNEH-HNNXBMFYSA-N
CAS Number
CAS 183720-28-7
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Potassium channel Target Info Modulator [1572591]
References
Ref 539459(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2307).
Ref 546835Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010536)
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.